Hypertransaminasemia in the course of infection with SARS-CoV-2: Incidence and pathogenetic hypothesis

doi:10.12998/wjcc.v8.i8.1385

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10873)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

678

WORD

257

HTML

5178

Figures (1-2)

341

Tables (1-1)

350

Sum=6804

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

723

Download

845

Sum=1568

Publishing Process of This Article

Item

Count

Browse

849

Download

1652

Sum=2501

Apr 26, 2020 (publication date) through Nov 5, 2024

Times Cited of This Article

Times Cited (23)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Cases. Apr 26, 2020; 8(8): 1385-1390
Published online Apr 26, 2020. doi: 10.12998/wjcc.v8.i8.1385

Full Size Figure Download Figure

Figure 1 Possible mechanisms underlying the liver damage. COVID-19: Coronavirus disease 2019.

Citation: Zippi M, Fiorino S, Occhigrossi G, Hong W. Hypertransaminasemia in the course of infection with SARS-CoV-2: Incidence and pathogenetic hypothesis. World J Clin Cases 2020; 8(8): 1385-1390
URL: https://www.wjgnet.com/2307-8960/full/v8/i8/1385.htm
DOI: https://dx.doi.org/10.12998/wjcc.v8.i8.1385